Pulmonic regurgitation cardiac MRI: Difference between revisions

Jump to navigation Jump to search
(/* ACC/AHA Guidelines- ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance{{cite journal| author=American College of Cardiology Foundation Task Force on Expert Consensus Documents. Hundley WG, Bluemke DA, Finn JP...)
Line 7: Line 7:


==Cardiac MRI==
==Cardiac MRI==
[[Cardiac magnetic resonance]](CMR) is a gold standard for assessment of morphology of the [[pulmonary valve]], for quantification of the severity of the regurgitation and the [[RV systolic function]].
[[Cardiac magnetic resonance]](CMR) is a gold standard for assessment of the morphology of the [[pulmonary valve]], for quantification of the severity of the regurgitation and the [[RV systolic function]].
*CMR is useful in quantification of the regurgitant volume and regurgitant fraction of PR by using sequences called “velocity- encoded phase-contrast images”.<ref name="pmid19164336">{{cite journal| author=Wald RM, Redington AN, Pereira A, Provost YL, Paul NS, Oechslin EN et al.| title=Refining the assessment of pulmonary regurgitation in adults after tetralogy of Fallot repair: should we be measuring regurgitant fraction or regurgitant volume? | journal=Eur Heart J | year= 2009 | volume= 30 | issue= 3 | pages= 356-61 | pmid=19164336 | doi=10.1093/eurheartj/ehn595 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19164336  }} </ref>
*CMR is useful in quantification of the regurgitant volume and regurgitant fraction of PR by using sequences called “velocity- encoded phase-contrast images”.<ref name="pmid19164336">{{cite journal| author=Wald RM, Redington AN, Pereira A, Provost YL, Paul NS, Oechslin EN et al.| title=Refining the assessment of pulmonary regurgitation in adults after tetralogy of Fallot repair: should we be measuring regurgitant fraction or regurgitant volume? | journal=Eur Heart J | year= 2009 | volume= 30 | issue= 3 | pages= 356-61 | pmid=19164336 | doi=10.1093/eurheartj/ehn595 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19164336  }} </ref>
*CMR is useful for evaluating pulmonary regurgitant fraction, RV end-diastolic and end- systolic volumes, and RV ejection fraction
*CMR is useful for evaluating pulmonary regurgitant fraction, RV end-diastolic and end-systolic volumes, and RV ejection fraction
*CMR is the diagnostic modality preffered to determine the requirement of reintervention in patients with repaired [[Tetralogy of Fallot|tetralogy of fallot]] and to assess the ventricular function and dimensions.
*CMR is the diagnostic modality preferred to determine the requirement of reintervention in patients with repaired [[Tetralogy of Fallot|tetralogy of fallot]] and to assess the ventricular function and dimensions.
[[File:Repaired-tetralogy-of-Fallot-the-roles-of-cardiovascular-magnetic-resonance-in-evaluating-1532-429X-13-9-S3.ogv.180p.vp9.webm|thumb|center|400px|Video clip of [[PR|pulmonary regurgitation]] (PR) post [[TOF]] repair. Evaluation of [[PR]] by ECG-gated cine phase contrast MR. Antegrade flow from the right ventricle (RV) to the Main [[Pulmonary Artery]] (MPA) is encoded red and retrograde flow from the MPA to the RV (PR) is encoded blue.<ref name="pmid21251297">{{cite journal |vauthors=Geva T |title=Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support |journal=J Cardiovasc Magn Reson |volume=13 |issue= |pages=9 |date=January 2011 |pmid=21251297 |pmc=3036629 |doi=10.1186/1532-429X-13-9 |url=}}</ref>]]


==ACC/AHA Guidelines- ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance<ref name="pmid20479157">{{cite journal| author=American College of Cardiology Foundation Task Force on Expert Consensus Documents. Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA et al.| title=ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. | journal=Circulation | year= 2010 | volume= 121 | issue= 22 | pages= 2462-508 | pmid=20479157 | doi=10.1161/CIR.0b013e3181d44a8f | pmc=PMC3034132 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20479157  }} </ref> (DO NOT EDIT)==
==ACC/AHA Guidelines- ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance<ref name="pmid20479157">{{cite journal| author=American College of Cardiology Foundation Task Force on Expert Consensus Documents. Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA et al.| title=ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. | journal=Circulation | year= 2010 | volume= 121 | issue= 22 | pages= 2462-508 | pmid=20479157 | doi=10.1161/CIR.0b013e3181d44a8f | pmc=PMC3034132 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20479157  }} </ref> (DO NOT EDIT)==

Revision as of 21:13, 4 August 2020

Pulmonic regurgitation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differential diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

Chest X-Ray

Echocardiography

Cardiac MRI

Severity Assessment

Treatment

Medical Therapy

Surgical therapy

Follow up

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2], Aysha Anwar, M.B.B.S[3]

Overview

Cardiac magnetic resonance(CMR) is a gold standard for assessment of morphology of the pulmonary valve, for quantification of the severity of the regurgitation and the RV systolic function. CMR is useful in quantification of the regurgitant volume and regurgitant fraction of PR by using sequences called “velocity- encoded phase-contrast images”.[1] CMR is useful for evaluating pulmonary regurgitant fraction, RV end-diastolic and end- systolic volumes, and RV ejection fraction. CMR is the diagnostic modality preffered to determine the requirement of re-intervention in patients with repaired tetralogy of Fallot and to assess the ventricular function and dimensions.

Cardiac MRI

Cardiac magnetic resonance(CMR) is a gold standard for assessment of the morphology of the pulmonary valve, for quantification of the severity of the regurgitation and the RV systolic function.

  • CMR is useful in quantification of the regurgitant volume and regurgitant fraction of PR by using sequences called “velocity- encoded phase-contrast images”.[1]
  • CMR is useful for evaluating pulmonary regurgitant fraction, RV end-diastolic and end-systolic volumes, and RV ejection fraction
  • CMR is the diagnostic modality preferred to determine the requirement of reintervention in patients with repaired tetralogy of fallot and to assess the ventricular function and dimensions.

File:Repaired-tetralogy-of-Fallot-the-roles-of-cardiovascular-magnetic-resonance-in-evaluating-1532-429X-13-9-S3.ogv.180p.vp9.webm

ACC/AHA Guidelines- ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance[3] (DO NOT EDIT)

CMR may be used for assessing individuals with valvular heart disease in which evaluation of valvular stenosis, regurgitation, para- or perivalvular masses, perivalvular complications of infectious processes, or prosthetic valve disease are needed. CMR may be useful in identifying serial changes in LV volumes or mass in patients with valvular dysfunction.

References

  1. 1.0 1.1 Wald RM, Redington AN, Pereira A, Provost YL, Paul NS, Oechslin EN; et al. (2009). "Refining the assessment of pulmonary regurgitation in adults after tetralogy of Fallot repair: should we be measuring regurgitant fraction or regurgitant volume?". Eur Heart J. 30 (3): 356–61. doi:10.1093/eurheartj/ehn595. PMID 19164336.
  2. Geva T (January 2011). "Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support". J Cardiovasc Magn Reson. 13: 9. doi:10.1186/1532-429X-13-9. PMC 3036629. PMID 21251297.
  3. American College of Cardiology Foundation Task Force on Expert Consensus Documents. Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA; et al. (2010). "ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents". Circulation. 121 (22): 2462–508. doi:10.1161/CIR.0b013e3181d44a8f. PMC 3034132. PMID 20479157.

Template:WH Template:WS